共 12 条
[1]
Preventi on ofstro kea nddementiawi thstatin s:effec tsbeyo ndlip idlowering. VaughanCJ. The American Journal of Cardiology . 2003
[2]
Use of statins inCNSdisorders. CucchiaraB,KasnerSE. Journal of the Neurological Sciences . 2001
[3]
Reduc ti onofplasma24S-hydroxycholesterol(cerebroste rol)le velsu singhigh-dosagesimvast at ininpati ents withhypercholesterolemia:evid ence thatsimvast atinaff ectscholesterolmetabo li smi ntheh umanbrains. LocatelliS,LutjohannD,Schmid tH H,etal. Archives of Neurology . 2002
[4]
Cholesteroli nAlzheim er’ sdis-easeandta u opathy. BurnsM,DuffK. Annals of the New York Academy of Sciences . 2002
[5]
Schumpe rtJ,Hi rt hV.The im pactoft he use ofstatinso nt heprevalenc eof dementiaand th eprogress ionofcognitiveimpairm ent. HajjarI. JGerontolABiolSciMedSci . 2002
[6]
Secr et ionof apol ipoprote inEbybraingliarequ ire sp roteinpren yl ationandissuppressedbystatins. N aiduA,XuQ,Ca talanoR,etal. Brain Research Bulletin . 2002
[7]
Statin effectsonchol es terol micro-domainsinbrainplasmamembranes. KirschC,Ecker tGP,Muell erWE. Biochemistry and Pharmacology . 2003
[8]
Apolipoprotein Eand Al zheimer ’sdisease.Arole inamyloidcatabolism. PoirierJ. Annals of the New York Academy of Sciences . 2000
[9]
Redu c- tionin levelsof24S-hydroxychole st erolbystatintre at mentinpa tientswithAlz heimerdisease. VegaGL,WeinerMF,Lip to nAM,etal. Archives of Neurology . 2003
[10]
Ap olipoprotei nEandcholes te rol metabo-lismi nth epathogen esisandtreatm entofAlzheimer’sdisease. PoirierJ. Trends in Molecular Medicine . 2003